Get startedLog in
    Picture of Ramm Pharma logo

    RAMM — Ramm Pharma Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Ramm Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

    2020
    October 31st
    2021
    October 31st
    2022
    October 31st
    2023
    October 31st
    2024
    October 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-7.43-7.11-21-7.72-16.5
    Depreciation
    Non-Cash Items4.291.5713.92.369.83
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-0.2390.9830.079-0.3661.47
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Cash from Operating Activities-2.91-3.82-5.91-4.39-4
    Capital Expenditures-1.89-0.43-0.168-0.062-0.047
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.334-6.4-0.9840.1890
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1.56-6.83-1.150.127-0.047
    Financing Cash Flow Items-0.205-0.01———
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2.91-0.19-0.354-0.41-0.258
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-7.36-10.9-7.38-4.66-4.3